Global Size of Liver Disease Diagnostics Market Will Gain USD 50.61 Billion By 2028

The global liver disease diagnostics market size is expected to reach USD 50.61 billion by 2028 according to a new study by Polaris Market Research.

Asia Pacific market for liver disease diagnostics is projected to witness lucrative growth over the assessment period. The rising geriatric population, increase in incidences rate of liver-related disorders, owing to rise in alcohol consumption, and awareness among individuals about regular checkups is contributing to the region’s market growth for liver disease diagnostics.

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, Table of Contents, Graphical introduction of regional analysis, Top players in the market with their revenue analysis and our research methodology.)

Moreover, a positive regulatory scenario towards advanced technologies with integrated imaging services also favored the market growth for liver disease diagnostics. In this direction, in August 2018, LiverMultiScan, an Australia-based company, received clearance to diagnose patients in Australia suffering from NAFLD and NASH diseases.

As per the market statistics published by the United Nations, through its World Population Prospects working group, in 2019, by 2050, there would be 1 in 6 old age people (over 65 years), as compared to 1 in 11 in 2019. This old age group accounts for one-fifth of the total population in 17 countries, and it is projected to be increased by the end of this century in 155 countries, covering 61 percent of the global population. This is mainly due to an increase in life expectancy and declining fertility rates among the people.

See also  Liver Disease Diagnostics Market Size Augmented to Exhibit the Value of USD size is expected to reach USD 50.61 billion by 2028

Request for Discount on this Report Before Purchase @

Top Market Players

Market participants such as Horiba Medical, Abbott, Fujifilm Corporation, Roche Ltd, Randox Laboratories Ltd., Boston Scientific Corporation, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, and Siemens Healthcare GmbH. are some of the key players operating in the market for liver disease diagnostics.

Key players in the market for liver disease diagnostics are undertaking initiatives to favor non-profit organizations to spread awareness and help patients in the diagnosis of liver abnormalities. In this direction, in January 2020, Echosens supported the U.S.-based academic institution Fatty Liver Foundation (FLF) through FibroScan to enable physicians in the diagnostics of liver-related diseases and disorders.

Browse detail report with in-depth TOC @

Polaris Market research has segmented the liver disease diagnostics market report on the basis of diagnosis technique, type, and region:


Liver Disease Diagnostics, Diagnosis Technique Outlook (Revenue – USD Million, 2016 – 2028)

  • Imaging
  • Laboratory tests
  • Endoscopy
  • Biopsy
  • Others

Liver Disease Diagnostics, End-Use Outlook (Revenue – USD Million, 2016 – 2028)

  • Hospitals
  • Laboratories
  • Others

About Us:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.